2673-8880

Frontiers in Nuclear Medicine

Frontiers Media SA

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 207 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact207 DOIs
2

Add abstracts to 23 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact23 DOIs
3

Deposit reference lists for 10 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact10 DOIs

DOIs for this ISSN

Showing the top 5 of 207 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 PET and SPECT Specialty Grand Challenge. When Knowledge Trav… (10.3389/fnume.2021.671914)
Abstract ORCID
55.70 12
2 Reconstruction-free positron emission imaging: Fact or ficti… (10.3389/fnume.2022.936091)
Abstract ORCID
42.25 6
3 The Application of in silico Methods for Prediction of Blood… (10.3389/fnume.2022.853475)
ORCID
40.32 40
4 Evaluation of deep space exploration risks and mitigations a… (10.3389/fnume.2023.1225034)
ORCID
39.21 36
5 PARALLELPROJ—an open-source framework for fast calculation o… (10.3389/fnume.2023.1324562)
ORCID
38.60 34
6 Correction: On the construction of a large-scale database of… (10.3389/fnume.2025.1671281)
Abstract References ORCID
35.78 2
7 Advances and challenges in immunoPET methodology (10.3389/fnume.2024.1360710)
ORCID
35.37 25
8 Broadening the selection criteria for Astronauts undertaking… (10.3389/fnume.2022.997718)
Abstract ORCID
34.95 4
9 Immunological effects of radiopharmaceutical therapy (10.3389/fnume.2024.1331364)
ORCID
34.95 24
10 Leveraging law and ethics to promote safe and reliable AI/ML… (10.3389/fnume.2022.983340)
ORCID
31.97 18
11 Theranostics in breast cancer (10.3389/fnume.2023.1236565)
ORCID
31.97 18
12 Bone Scintigraphy of Vertebral Fractures With a Whole-Body C… (10.3389/fnume.2021.740275)
ORCID
31.38 17
13 Normal Variants, Pitfalls and Artifacts in Ga-68 DOTATATE PE… (10.3389/fnume.2022.825486)
ORCID
31.38 17
14 Clinical Relevance of Nuclear Magnetic Resonance LipoProfile (10.3389/fnume.2022.960522)
ORCID
31.38 17
15 Lutetium background radiation in total-body PET—A simulation… (10.3389/fnume.2022.963067)
ORCID
31.38 17
16 Mini review of first-in-human integrin αvβ6 PET tracers (10.3389/fnume.2023.1271208)
ORCID
30.76 16
17 Quantitative imaging for 177Lu-PSMA treatment response monit… (10.3389/fnume.2023.1291253)
ORCID
30.76 16
18 Motion-correction strategies for enhancing whole-body PET im… (10.3389/fnume.2024.1257880)
ORCID
30.76 16
19 Terbium sisters: current development status and upscaling op… (10.3389/fnume.2024.1472500)
ORCID
30.76 16
20 PET tracers in glioblastoma: Toward neurotheranostics as an… (10.3389/fnume.2023.1103262)
ORCID
30.10 15
21 Automatic deep learning method for third lumbar selection an… (10.3389/fnume.2023.1292676)
ORCID
30.10 15
22 Synthesis of Radiopharmaceuticals via “In-Loop” 11C-Carbonyl… (10.3389/fnume.2021.820235)
ORCID
29.40 14
23 Normal Variants, Pitfalls, and Artifacts in Ga-68 Prostate S… (10.3389/fnume.2022.825512)
ORCID
29.40 14
24 Multicentric 68Ga-PSMA PET radiomics for treatment response… (10.3389/fnume.2023.1234853)
ORCID
29.40 14
25 Activity quantification and dosimetry in radiopharmaceutical… (10.3389/fnume.2024.1355912)
ORCID
29.40 14
26 Recent advances in PET-MRI for cardiac sarcoidosis (10.3389/fnume.2022.1032444)
ORCID
28.65 13
27 αvβ6-integrin targeted PET/CT imaging in pancreatic cancer p… (10.3389/fnume.2024.1487602)
ORCID
28.65 13
28 Normal Variants and Pitfalls of 18F-FDG PET/CT Imaging in Pe… (10.3389/fnume.2022.825891)
ORCID
27.85 12
29 18F-FDG PET/CT Imaging: Normal Variants, Pitfalls, and Artif… (10.3389/fnume.2022.847810)
ORCID
27.85 12
30 Radiomics insight into the neurodegenerative “hot” brain: A… (10.3389/fnume.2023.1143256)
ORCID
27.85 12
31 Myocardial Blood Flow and Flow Reserve in Patients With Acut… (10.3389/fnume.2022.935539)
ORCID
26.98 11
32 Deep-learning-derived input function in dynamic [18F]FDG PET… (10.3389/fnume.2024.1372379)
ORCID
26.98 11
33 Radiosynthesis of [11C]Ibrutinib via Pd-Mediated [11C]CO Car… (10.3389/fnume.2021.772289)
ORCID
26.03 10
34 F-18 FDG PET/CT Imaging in Normal Variants, Pitfalls and Art… (10.3389/fnume.2021.826109)
ORCID
26.03 10
35 Radiopharmaceutical good practices: Regulation between hospi… (10.3389/fnume.2022.990330)
ORCID
26.03 10
36 A brief overview of targeted radionuclide therapy trials in… (10.3389/fnume.2023.1169650)
ORCID
26.03 10
37 Tumor microenvironment and fibroblast activation protein inh… (10.3389/fnume.2023.1183471)
ORCID
26.03 10
38 Comparative effectiveness of standard vs. AI-assisted PET/CT… (10.3389/fnume.2023.1327186)
ORCID
26.03 10
39 The complementary role of MRI and FET PET in high-grade glio… (10.3389/fnume.2023.1040998)
ORCID
25.00 9
40 A fast Monte Carlo cell-by-cell simulation for radiobiologic… (10.3389/fnume.2023.1284558)
ORCID
25.00 9
41 Ionising radiation exposure-induced regulation of selected b… (10.3389/fnume.2024.1469897)
ORCID
25.00 9
42 18F-FDG PET/CT and MRI in the Management of Multiple Myeloma… (10.3389/fnume.2021.808627)
ORCID
23.86 8
43 DOTA Conjugate of Bisphosphonate and PSMA-Inhibitor: A Promi… (10.3389/fnume.2022.892147)
ORCID
23.86 8
44 Population-based input function (PBIF) applied to dynamic wh… (10.3389/fnume.2022.941848)
ORCID
23.86 8
45 Preclinical antibody-PET imaging of PD-L1 (10.3389/fnume.2022.953202)
ORCID
23.86 8
46 A heterogeneous phantom study for investigating the stabilit… (10.3389/fnume.2023.1078536)
ORCID
23.86 8
47 Utilizing MRI, [18F]FDG-PET and [89Zr]Zr-DFO-28H1 FAP-PET tr… (10.3389/fnume.2023.1306251)
ORCID
23.86 8
48 Recent clinical advances in fibroblast activation protein ta… (10.3389/fnume.2025.1737443)
ORCID
23.86 8
49 A multi-object deep neural network architecture to detect pr… (10.3389/fnume.2022.1083245)
ORCID
22.58 7
50 An Update to the Pilot Study of 177Lu-PSMA in Low Volume Hor… (10.3389/fnume.2022.863101)
ORCID
22.58 7